BioCentury
ARTICLE | Company News

Management tracks

October 6, 2016 7:00 AM UTC

Chiasma Inc. (NASDAQ:CHMA) said President and CEO Mark Leuchtenberger left the endocrine company. CFO Mark Fitzpatrick will succeed him.

Oncology company BeiGene Ltd. (NASDAQ:BGNE) named Ross Pettit SVP of global development operations. He was SVP of development operations at Infinity Pharmaceuticals Inc. (NASDAQ:INFI). ...